1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Lucy Scientific Discovery Inc.

Lucy Scientific Discovery Inc.

LSDI
Lucy Scientific Discovery Inc.US flagNASDAQ Capital Market
0.51
USD
-0.16
- -
906,910.00Market Cap

Total Valuation

Lucy Scientific Discovery Inc. carries a market capitalization of 906,910.00, placing it among publicly traded companies globally. Its enterprise value stands at 6.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap906,910.00
Enterprise Value6.17M

Share Statistics

Lucy Scientific Discovery Inc. currently has 1.76M shares outstanding.

Shares Outstanding1.76M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 249.20, and the price-to-book ratio stands at -6,186.29.

PE RatioN/A
PS Ratio249.20
PB Ratio-6,186.29
P/TBV Ratio-3.06
P/FCF Ratio-0.76
P/OCF Ratio-0.70

Enterprise Valuation

EV / Sales368.85
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Lucy Scientific Discovery Inc. maintains a current ratio of 0.38, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2,727.07, indicating elevated leverage, while an interest coverage ratio of -4.61 demonstrates limited ability to service its debt obligations.

Current Ratio0.38
Quick Ratio0.06
Debt / Equity2,727.07
Debt / EBITDA-0.33
Interest Coverage-4.61

Financial Efficiency

Return on Equity (ROE)-262.20
Return on Assets (ROA)-249.36
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

Lucy Scientific Discovery Inc.'s stock has declined approximately -95.21953% over the past 52 weeks. The 50-day moving average sits at 0.88, while the 200-day moving average is 2.28.

Beta (5Y)N/A
52-Week Price Change-95.21953%
50-Day Moving Average0.88
200-Day Moving Average2.28
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Lucy Scientific Discovery Inc. generated 16,732.00 in revenue and converted that into -11.30M in net income, yielding earnings per share of -6.13. EBITDA reached -6.72M, while operating income came in at -6.86M.

Revenue16,732.00
Gross Profit5,816.00
Operating Income-6.86M
Pretax Income-9.98M
Net Income-11.30M
EBITDA-6.72M
EBIT-6.86M
Earnings Per Share (EPS)-6.13

Balance Sheet

Lucy Scientific Discovery Inc. holds 211,120.00 in cash and equivalents against 2.21M in total debt, resulting in a net debt position of 925,194.00. Total book value stands at -674.00, with working capital of -2.15M providing operational flexibility.

Cash & Cash Equivalents211,120.00
Total Debt2.21M
Net Debt925,194.00
Equity (Book Value)-674.00
Book Value Per Share0.00
Working Capital-2.15M

Cash Flow

Lucy Scientific Discovery Inc. produced -5.92M in operating cash flow over the past twelve months. After subtracting -423,000.00 in capital expenditures, free cash flow totaled -6.35M - equivalent to -3.90 per share.

Operating Cash Flow-5.92M
Capital Expenditures-423,000.00
Free Cash Flow-6.35M
FCF Per Share-3.90

Margins

Lucy Scientific Discovery Inc. operates with a gross margin of 76.88, reflecting its pricing power and cost economics. The operating margin of -41,005.83 and net profit margin of -67,538.16 provide insight into operational efficiency.

Gross Margin76.88
Operating Margin-41,005.83
Pretax Margin-59,674.28
Profit Margin-67,538.16
EBITDA Margin-40,168.98

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-159.21
FCF Yield-131.92

Stock Splits

Lucy Scientific Discovery Inc.'s most recent stock split took place on February 26, 2024 with a 10:1 split ratio.

Last Split Date2/26/2024
Split Ratio10:1

Scores

Lucy Scientific Discovery Inc. posts an Altman Z-Score of -32.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-32.43